Clinical experience with pegaptanib sodium

Pegaptanib sodium (Macugen(®)) blocks the extracellular vascular endothelial growth factor (VEGF) isoform VEGF(165), whose elevated levels are associated with the development of choroidal neovascularization (CNV). This selective inhibition prevents binding to the VEGF receptors and the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosina, Chiara, Bottoni, Ferdinando, Staurenghi, Giovanni
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694030/
https://www.ncbi.nlm.nih.gov/pubmed/19668746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694030/
https://www.ncbi.nlm.nih.gov/pubmed/19668746

Ejemplares similares